PA
ELV icon

Prism Advisors’s Elevance Health ELV Stock Holding History

Prism Advisors’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-757
Closed -$217K – 60
2019
Q1 		$217K Buy
+757
New +$219K 0.12% 55
2018
Q4 		– Sell
-786
Closed -$217K – 55
2018
Q3 		$217K Sell
786
-91
-10% -$23.6K 0.13% 52
2018
Q2 		$212K Sell
877
-93
-10% -$21.5K 0.11% 52
2018
Q1 		$219K Sell
970
-12,481
-93% -$2.93M 0.12% 50
2017
Q4 		$3.03M Buy
+13,451
New +$2.86M 1.67% 11

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Prism Advisors's ELV Position: Q2 2019 in Review

Prism Advisors sold out of Elevance Health (ELV) in Q2 2019, closing a stake of 757 shares — an estimated $217K sold.

Prism Advisors first reported a position in ELV in Q4 2017 and held it in 5 quarters. The position peaked at $3.03M in Q4 2017. 1,030 funds tracked by Wall St. Rank hold ELV as of Q2 2019.

  • Prism Advisors reported no remaining Elevance Health position as of Q2 2019 after selling out during the quarter.
  • Prism Advisors sold 757 Elevance Health shares in Q2 2019, an estimated $217K.
  • Prism Advisors first reported a position in Elevance Health in Q4 2017 and held it in 5 quarters.
  • Prism Advisors's Elevance Health position peaked at $3.03M in Q4 2017.
  • 1,030 funds tracked by Wall St. Rank held Elevance Health as of Q2 2019.

Based on Prism Advisors's 13F filing for Q2 2019, filed 6 Aug 2019.